The Weekly Recap 12/5/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure new funding, receive regulatory approvals, achieve clinical milestones, and much more on the road to LSI USA ’26 in Dana Point (March 16–20).

AccuLine

Welcomed LSI Alumni Joe Mullings to its Advisory Board, bringing one of the most connected and trusted leaders in global medtech to support the company’s growth. Mullings’ strategic guidance and industry-wide reach will help AccuLine scale its CORA platform in the U.S. and advance toward its Series A.

Akura Medical

Announced a $53M first close in its Series C financing to advance development of the Katana™ Thrombectomy System and NavIQ™ quantification software. The funding will also support completion of QUADRA-PE enrollment, regulatory submissions, and the establishment of a joint venture in Qatar.

Atraverse Medical

Secured FDA 510(k) clearance for its fully integrated HOTWIRE™ Transseptal Access System, which includes the HOTWIRE RF Guidewire and the HOTWIRE RF Generator. The company also shared that the HOTWIRE RF Guidewire, which received 510(k) clearance in May of 2024, has now been successfully used in nearly 2,000 clinical procedures.

Avisi Technologies

Treated the first patient in the SAPPHIRE Trial evaluating the VisiPlateⓇ glaucoma treatment device in patients with open-angle glaucoma. The procedure marks the start of the prospective, multicenter, open-label trial, which will assess safety and effectiveness to support future FDA applications.

FIZE Medical

Announced the launch of the FIZE kUOⓇ system in Japan through an exclusive partnership with Asahi Kasei Medical. The collaboration expands access to real-time kidney insights for ICU teams, supporting earlier detection of deterioration and more precise, data-driven fluid management at the bedside.

FluidAI Medical

Announced an acquisition deal with Emmetros Limited to enhance Stream Inara™, its AI-powered patient education and engagement platform. Emmetros is the developer of SparxConnect™, a secure, customizable engagement and collaboration platform for home, residential, and surgical care.

Francis Medical

Received FDA 510(k) clearance for the VanquishⓇ Water Vapor Ablation System for prostate tissue ablation in intermediate-risk prostate cancer. The clearance, supported by positive VAPOR 2 study data, enables commercial launch and advances the company toward expanded indications.

This blog is originally published here: https://www.lifesciencemarketresearch.com/insights/the-weekly-recap-12525-lsi-alumni-achievements-driving-medtech-and-healthtech-forward

Comments

Post a Comment

Popular posts from this blog

Cover Story: A Page from Ray Cohen’s Playbook: Scaling, Exiting, and Winning in Medtech

With four decades of company-building, IPOs, boardroom leadership, and monumental exits behind him, Raymond W. Cohen has become one of medtech’s most successful operators. But behind the financial wins — including the recent back-to-back $3.7 billion Axonics and $600 million SoniVie acquisitions by Boston Scientific — is a deeper story of Cohen’s contrarian, full-transparency, people-centered, no-BS approach to leadership and strategy. “People crave inspired, authentic, and transparent leadership that thinks big and acts boldly. They want to be enrolled in a vision of what is possible, and be recognized and compensated for creating measurable results, not be fed a bunch of platitudes.” A quote that is classic  Ray Cohen  — blunt, unapologetic, no-nonsense, and grounded in hard-won experience. With more than four decades in medtech, Cohen has done what many aspire to — build, lead, scale, and sell high-stakes, successful ventures with precision and zero fluff. Known for his no-...
Read more

The Weekly Recap 6/13/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure over $63M in new funds, receive FDA 510(k) clearances, announce an acquisition, and much more as we wind down   LSI Asia  ’25 in Singapore and gear up for  LSI Europe  ’25 in London (September 7–11). Accelus Received FDA 510(k) clearance for the FlareHawk Interbody Fusion System to be safely subjected to MRI scanning in certain conditions. The clearance supports Accelus’s commitment to safe, high-performance spinal solutions and expands imaging options for patients with FlareHawk implants. Aortyx Raised $16M to advance its bioresorbable aortic patch toward first-in-human trials. The funding supports continued development of Aortyx’s minimally invasive, tissue-regenerating solution for aortic dissection and positions the company for clinical entry within two years. Atraverse Medical Closed $29.4M in follow-on financing to scale U.S. commercialization of HOTW...
Read more

Medtech in 2025: Key Insights from Q1 Earnings

  As we venture into Q2 of 2025, the medtech industry continues to navigate challenges while remaining on a positive growth trajectory. The early earnings reports from major medtech companies provide valuable insights into how the sector is performing and where it is heading. Despite the pressures of ongoing macroeconomic uncertainty, the first quarter of 2025 shows a sector that’s resilient, with many companies reporting strong growth across their key divisions. For more information visit here:  https://www.slideshare.net/slideshow/medtech-in-2025-key-insights-from-q1-earnings/279045324
Read more